15 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
17
Discovery of a novel pyrazole series of group X secreted phospholipase A2 inhibitor (sPLA2X) via fragment based virtual screening.

AstraZeneca
7
Inhibition of secreted phospholipases A2 by 2-oxoamides based ona-amino acids: Synthesis, in vitro evaluation and molecular docking calculations.

University of Athens
15
Simplified YM-26734 inhibitors of secreted phospholipase A2 group IIA.

University of Washington
23
Highly specific and broadly potent inhibitors of mammalian secreted phospholipases A2.

University of Washington
8
Inhibitory effect of synthetic C-C biflavones on various phospholipase A(2)s activity.

Yeungnam University
24
Inhibition of secreted phospholipase A2. 4-glycerol derivatives of 4,5-dihydro-3-(4-tetradecyloxybenzyl)-1,2,4-4H-oxadiazol-5-one with broad activities.

Université
5
In silico-guided target identification of a scaffold-focused library: 1,3,5-triazepan-2,6-diones as novel phospholipase A2 inhibitors.

Cnrs Umr 7175
4
The first potent inhibitor of mammalian group X secreted phospholipase A2: elucidation of sites for enhanced binding.

University of Washington
28
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities.

Niddk
147
Functionalized quinoxalinones as privileged structures with broad-ranging pharmacological activities.

Central South University
3
Quinoline-4-acetamides as sPLA(2) inhibitors.

Peking University
12
Discovery of AZD2716: A Novel Secreted Phospholipase A

AstraZeneca
14
Discovery of new non-phospholipid inhibitors of the secretory phospholipases A2.

Fisons
18
Design of Selective sPLA

AstraZeneca
27
Discovery of a Series of Indole-2 Carboxamides as Selective Secreted Phospholipase A

AstraZeneca